Innoviva Income Taxes 2010-2024 | INVA
Innoviva income taxes from 2010 to 2024. Income taxes can be defined as the total amount of income tax expense for the given period.
Innoviva Annual Income Taxes
(Millions of US $) |
| 2024 |
$14 |
| 2023 |
$14 |
| 2022 |
$67 |
| 2021 |
$76 |
| 2020 |
$60 |
| 2019 |
$42 |
| 2018 |
$-196 |
| 2017 |
$0 |
| 2016 |
$0 |
| 2015 |
$ |
| 2014 |
$ |
| 2013 |
$ |
| 2012 |
$ |
| 2011 |
$ |
| 2010 |
$ |
| 2009 |
$ |
Innoviva Quarterly Income Taxes
(Millions of US $) |
| 2024-12-31 |
$4 |
| 2024-09-30 |
$6 |
| 2024-06-30 |
$-5 |
| 2024-03-31 |
$9 |
| 2023-12-31 |
$-0 |
| 2023-09-30 |
$4 |
| 2023-06-30 |
$5 |
| 2023-03-31 |
$6 |
| 2022-12-31 |
$4 |
| 2022-09-30 |
$57 |
| 2022-06-30 |
$-1 |
| 2022-03-31 |
$7 |
| 2021-12-31 |
$11 |
| 2021-09-30 |
$21 |
| 2021-06-30 |
$25 |
| 2021-03-31 |
$20 |
| 2020-12-31 |
$16 |
| 2020-09-30 |
$9 |
| 2020-06-30 |
$20 |
| 2020-03-31 |
$16 |
| 2019-12-31 |
$12 |
| 2019-09-30 |
$11 |
| 2019-06-30 |
$10 |
| 2019-03-31 |
$9 |
| 2018-12-31 |
|
| 2018-09-30 |
|
| 2018-06-30 |
|
| 2018-03-31 |
|
| 2017-12-31 |
|
| 2017-09-30 |
|
| 2017-06-30 |
|
| 2017-03-31 |
|
| 2016-12-31 |
|
| 2016-09-30 |
|
| 2016-06-30 |
|
| 2016-03-31 |
|
| 2015-12-31 |
|
| 2015-09-30 |
|
| 2015-06-30 |
|
| 2015-03-31 |
|
| 2014-12-31 |
|
| 2014-09-30 |
$-0 |
| 2014-06-30 |
$0 |
| 2014-03-31 |
|
| 2013-12-31 |
|
| 2013-09-30 |
|
| 2013-06-30 |
|
| 2013-03-31 |
|
| 2012-12-31 |
|
| 2012-09-30 |
|
| 2012-06-30 |
|
| 2012-03-31 |
|
| 2011-12-31 |
|
| 2011-09-30 |
|
| 2011-06-30 |
|
| 2011-03-31 |
|
| 2010-12-31 |
|
| 2010-09-30 |
|
| 2010-06-30 |
|
| 2010-03-31 |
|
| 2009-12-31 |
|
| 2009-09-30 |
|
| 2009-06-30 |
|
| 2009-03-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharmaceutical |
$1.132B |
$0.310B |
|
Innoviva, Inc. is focused on the development, commercialization and financial management of bio-pharmaceuticals. The company's portfolio of respiratory assets partnered with Glaxo Group Limited, including RELVAR(R)/BREO(R) ELLIPTA(R) and ANORO(R) ELLIPTA(R). Innoviva, Inc., formerly known as Theravance, Inc., is headquartered in South San Francisco, California.
|
